rs140140417
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_016239.4(MYO15A):c.8269G>A(p.Val2757Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00185 in 1,613,966 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.8269G>A | p.Val2757Met | missense_variant | 46/66 | ENST00000647165.2 | NP_057323.3 | |
LOC105371567 | XR_001752809.1 | n.89+98C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO15A | ENST00000647165.2 | c.8269G>A | p.Val2757Met | missense_variant | 46/66 | NM_016239.4 | ENSP00000495481 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00157 AC: 239AN: 152222Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00233 AC: 579AN: 248928Hom.: 2 AF XY: 0.00237 AC XY: 320AN XY: 135192
GnomAD4 exome AF: 0.00188 AC: 2747AN: 1461626Hom.: 9 Cov.: 32 AF XY: 0.00205 AC XY: 1491AN XY: 727106
GnomAD4 genome AF: 0.00158 AC: 241AN: 152340Hom.: 1 Cov.: 33 AF XY: 0.00154 AC XY: 115AN XY: 74500
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 08, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | MYO15A: BS2 - |
Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jul 30, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 15, 2016 | p.Val2757Met in exon 46 of MYO15A: This variant is not expected to have clinical significance due to a lack of conservation across species, including mammals. Of note, hedgehog, elephant, hyrax and platypus have a methionine (Met) at this position despite high nearby amino acid conservation. In addition, this variant has been identified in 0.6% (94/16282) of South Asian chromosomes including 1 ho mozygote by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs140140417). - |
MYO15A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 17, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at